Lancashire and South Cumbria
Formulary
 
back
6 Endocrine system
06-01-01-03 Hypodermic equipment

Insulin pumps
Formulary

For supply via secondary care only with Blueteq approval.

Classified as Red Red in secondary care and
Do Not Prescribe in Primary Care


Prescribable CGM
Formulary

FreeStyle Libre, Dexcom

Red FreeStyle Libre® 3. Freestyle Libre 3 will be discontinued in March 2026. Patients considered appropriate for Freestyle Libre 3 will need to be initiated on or switched to the updated device: Freestyle Libre 3 Plus.

Only for patients with a diagnosis of diabetes.

For patients who do not routinely attend appointments with specialist clinicians prescribable CGM may be supplied in primary care by a clinician responsible for the wider care and management of the patient’s diabetes.
 
For recommendations on the supply of CGM please consult the following NICE guidelines:
NICE NG28: Type 2 diabetes in adults: management Section 1.7.1 - 1.7.10
NICE NG17: Type 1 diabetes in adults: diagnosis and management Section 1.6.10 - 1.6.18
NICE NG 18: Diabetes (type 1 and type 2) in children and young people: diagnosis and management  Section 1.2.60 - 1.2.70
NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period Section 1.3.17-1.3.20

Amber 0